Hydroxyurea
FDA Approved
Description
Hydroxyurea is an antimetabolite used to treat certain cancers and sickle cell anemia. It inhibits DNA synthesis without affecting RNA or protein synthesis.
Indications & Therapeutic Use
Choriocarcinoma of ovary
Linked Diseases:
Global Availability (2 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Hydroxyurea
| Generic Name | Hydroxyurea |
| Brands | 1 brand available |
| Active Ingredient | Hydroxyurea |
| Drug Class | Choriocarcinoma of ovary |
| Manufacturer | Bristol-Myers Squibb |
| Dosage Forms | Capsule |
| Medical Code | L01XX05 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 2 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations3 Validated Nodes